EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana

Michael G Milligan, Elizabeth Bigger, Jeremy S Abramson, Aliyah R Sohani, Musimar Zola, Mukendi K A Kayembe, Heluf Medhin, Gita Suneja, Shahin Lockman, Bruce A Chabner, Scott L Dryden-Peterson

Journal of Global Oncology · 2018-12 · (4) · 1-11

DOI: 10.1200/jgo.17.00084 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Global Oncology, 2018-12. Verfasst von Michael G Milligan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. Milligan, Jeremy S. Abramson, Aliyah R. Sohani, Shahin Lockman, Bruce A. Chabner, and Scott L. Dryden-Peterson, Harvard Medical School; El…. Hauptthemen laut MEDLINE: Antiretroviral Therapy, Highly Active. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Botswana has a high prevalence of HIV infection. Currently, there are few data regarding the sociodemographic factors, clinical characteristics, and outcomes of non-Hodgkin lymphoma (NHL)—an AIDS-defining cancer—in the country. Patients and Methods This study used a prospective cancer registry to identify patients with a new diagnosis of NHL reporting for specialty cancer care at three hospitals in Botswana between October 2010 and August 2016. Treatment patterns and clinical outcomes were analyzed.

Results

One hundred four patients with a new diagnosis of NHL were enrolled in this study, 72% of whom had HIV infection. Compared with patients not infected with HIV, patients infected with HIV were younger (median age, 53.9 v 39.1 years; P = .001) and more likely to present with an aggressive subtype of NHL (65.5% v 84.0%; P = .008). All patients infected with HIV received combined antiretroviral therapy throughout the course of the study, and similar chemotherapeutic regimens were recommended for all patients, regardless of subtype or HIV status (six to eight cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone; or cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab). There was no difference in 1-year mortality among patients not infected with HIV and patients infected with HIV (unadjusted analysis, 52.9% v 37.1%; hazard ratio [HR], 0.73; P = .33; adjusted analysis, HR, 0.57; P = .14). However, when compared with a cohort of patients in the United States matched by subtype, stage, age, sex, and race, patients in Botswana fared worse (1-year mortality, 22.8% v 46.3%; HR, 1.89; P = .001).

Conclusion

Among patients with NHL reporting for specialty cancer care in Botswana, there is no association between HIV status and 1-year survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiretroviral Therapy, Highly ActiveAdolescentAdultAntineoplastic Combined Chemotherapy ProtocolsBotswanaCyclophosphamideDoxorubicinFemaleHIV InfectionsHumansLymphoma, AIDS-RelatedLymphoma, Non-HodgkinMaleMiddle AgedPrednisoneProspective StudiesRituximabTreatment OutcomeUnited StatesVincristine

Substanzen

RituximabVincristineDoxorubicinCyclophosphamidePrednisone

Autor:innen und Institutionen

  • Michael G. Milligan, Jeremy S. Abramson, Aliyah R. Sohani, Shahin Lockman, Bruce A. Chabner, and Scott L. Dryden-Peterson, Harvard Medical School; Elizabeth Bigger, Jeremy S. Abramson, and Aliyah R. Sohani, Massachusett…

Förderung

  • NIAID NIH HHS

Zitieren

APA

Milligan, M. G., Bigger, E., Abramson, J. S., Sohani, A. R., Zola, M., Kayembe, M. K. A., Medhin, H., Suneja, G., Lockman, S., Chabner, B. A., & Dryden-Peterson, S. L. (2018). Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana. Journal of Global Oncology, 1-11. https://doi.org/10.1200/jgo.17.00084

Vancouver

Milligan MG, Bigger E, Abramson JS, Sohani AR, Zola M, Kayembe MKA, et al. Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana. Journal of Global Oncology. 2018:1-11. doi:10.1200/jgo.17.00084

BibTeX
@article{Milligan2018,
  author = {Milligan, Michael G and Bigger, Elizabeth and Abramson, Jeremy S and Sohani, Aliyah R and Zola, Musimar and Kayembe, Mukendi K A and Medhin, Heluf and Suneja, Gita and Lockman, Shahin and Chabner, Bruce A and Dryden-Peterson, Scott L},
  title = {Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana},
  journal = {Journal of Global Oncology},
  year = {2018},
  number = {4},
  pages = {1--11},
  doi = {10.1200/jgo.17.00084}
}
Kostenlos starten →